Regulators of G Protein Signaling Proteins as Determinants of the Rate of Desensitization of Presynaptic Calcium Channels*

María A. Diversé-PierluissiDagger §, Thierry Fischerparallel , J. Dedrick Jordan§, Max Schiff§, Daniel F. OrtizDagger , Marilyn G. Farquharparallel , and Luc De Vriesparallel

From the § Department of Pharmacology, Mount Sinai School of Medicine, New York, New York 10029, the Dagger  Department of Physiology, Tufts University School of Medicine, Boston, Massachusetts 02111, and the parallel  Division of Cellular and Molecular Medicine and Department of Pathology, University of California, San Diego, La Jolla, California 92093-0651

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Norepinephrine inhibits omega -conotoxin GVIA-sensitive presynaptic Ca2+ channels in chick dorsal root ganglion neurons through two pathways, one mediated by Go and the other by Gi. These pathways desensitize at different rates. We have found that recombinant Galpha interacting protein (GAIP) and regulators of G protein signaling (RGS)4 selectively accelerate the rate of desensitization of Go- and Gi-mediated pathways, respectively. Blockade of endogenous RGS proteins using antibodies raised against Galpha interacting protein and RGS4 slows the rate of desensitization of these pathways in a selective manner. These results demonstrate that different RGS proteins may interact with Gi and Go selectively, giving rise to distinct time courses of transmitter-mediated effects.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Voltage-dependent calcium channels are the primary triggers for electrically evoked release of chemical transmitters. Understanding the mechanisms underlying their regulation is central to the development of a molecular picture of key events in neuronal signaling. Calcium channels are well known targets for inhibition by receptor-G protein pathways, and multiple forms of inhibition have been described (1, 2). The termination of the response or desensitization represents a main mechanism for controlling synaptic strength in an activity-dependent manner. Much of the knowledge about agonist-dependent desensitization comes from studies of ionotropic receptors such as GABAergic1 and glutamatergic receptors. In addition to the ionotropic receptor-mediated fast synaptic transmission, signaling in the nervous system relies heavily on G protein-coupled receptors for more prolonged and sustained synaptic action.

Norepinephrine (NE) inhibits N-type (omega -conotoxin GVIA-sensitive) Ca2+ channels in embryonic dorsal root ganglion (DRG) neurons through two pathways (3, 4), one mediated by Go and the other by Gi. Low concentrations of NE (<10 µM) produce reductions in N current with no changes in its time course of activation (termed "steady-state inhibition" (SSI)), whereas higher NE concentrations (>10 µM) evoke a slowing of the activation kinetics termed "kinetic slowing" (KS) (3). Use of purified G protein subunits has demonstrated that KS induced by NE requires the activation of Go, and alpha o is the functional subunit (4). By contrast, SSI is mediated by beta gamma released from Gi (4) and requires the activation of protein kinase C. Depolarizing prepulses reverse KS, leaving SSI unaffected (5).

This inhibition of the N-type calcium current is a transient phenomenon as the response desensitizes under prolonged exposure to 100 µM NE (6). The onset of desensitization in DRG neurons requires receptor-mediated G protein activation.2 Although both KS and SSI require the activation of the same G protein-coupled receptor kinase, GRK3 (6), each exhibits different rates of desensitization.

Recently, a new family of proteins, regulators of G protein signaling (RGS), has been found to play a role in desensitization (7-14). RGS proteins block G protein function by accelerating the rate of GTP hydrolysis (15, 16). Experiments presented in this paper show that RGS proteins selectively alter the time course of desensitization of the two signaling pathways. Although recent reports have shown that there is selectivity in the actions of RGS proteins on Gq- and Gi-mediated pathways (17, 18), little is known about the ability of these proteins to interact with different members of the Gi subfamily. Here we show that RGS4 and GAIP selectively interact with the Gi- and Go-mediated pathways. RGS4 alters the rate of desensitization of the Gi- and voltage-independent inhibition of calcium current whereas GAIP accelerates the rate of desensitization of the Go- and voltage-dependent inhibition of calcium current. Furthermore, our data suggest that a domain outside of the RGS domain might be responsible for the G protein subtype selectivity in RGS actions.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cell Culture-- Embryonic chick sensory neurons were grown in culture as described previously (3). Dorsal root ganglia were dissected from 11-12-day-old embryos. Cells were plated at a density of ~50,000 cells per collagen-coated 35-mm tissue culture dish and studied between 1 and 3 days in vitro.

Electrophysiology-- Whole-cell recordings were performed as described previously (19). For extracellular application, agents were diluted into standard extracellular saline and applied via a wide-bore (140 µm inner diameter) pipette, which exchanges solutions with subsecond kinetics. For the experiments presented in this report, calcium current has been corrected for rundown by measuring calcium current as a function of time in control cells without transmitter. Cells used for experiments exhibited a rundown of the current of <1%/min.

Data Analysis-- Data were filtered at 3 kHz, acquired at 10-20 kHz, and analyzed using PulseFit (HEKA) and Igor (WaveMetrics) on a Macintosh computer. Strong depolarizing conditioning pulses (to 80 mV) that precede test pulses (to 0 mV) reverse NE-induced KS without affecting SSI. Such conditioning pulses have no effect on control currents recorded in the absence of NE. During the application of the transmitter, test pulse currents measured before and after the conditioning pulse are subtracted to yield the KS component. Test pulses measured following the conditioning pulse are subtracted from control currents (measured in the absence of NE) to yield the SSI component. Integration of these two currents gives measurements of total charge entry carried by the two modulatory components.

Recombinant Proteins-- Rat pGBT9 Galpha o1 (originally a gift from E. Neer (9)), human GAIP-(1-217), human RGS4 (a generous gift from Dr. Druey), and the RGS domain of rat GAIP-(80-206) were subcloned in pET28a (Novagen) and expressed in Escherichia coli BL21 (DE3) host. Bacteria pellets were resuspended in 25 mM Tris (pH 8), 500 mM NaCl, 5 mM imidazole, 1% Tween 20, and 200 µg/ml lyzozyme for GAIP/RGS4 constructs, or 20 mM HEPES (pH 7.4), 500 mM NaCl, 5 mM imidazole, 2 mM MgCl2, 30 µM AlCl3, 20 mM NaF, 100 µM GDP, 1% Tween 20, and 200 µg/ml lyzozyme for Galpha o1. After sonication, 100,000 × g supernatants were applied to Ni2+-nitrilotriacetate resin (Qiagen, Chatsworth, CA), and histidine-tagged proteins were eluted with 250 mM imidazole.

GTPase-activating Protein Assays-- 250 nM Galpha o1 was loaded with [gamma -32P]GTP (1 µM) for 40 min in 50 mM HEPES (pH 8.0), 5 mM EDTA, 1 mM dithiothreitol, and 0.05% polyoxyethylene 10 lauryl ether (C12E10) at 30 °C. The temperature was then reduced to 4 °C. All GTP hydrolysis measures were performed under single turnover conditions at 4 °C (15). Reactions were started by addition of RGS mix consisting of 15 mM MgSO4, 150 µM GTP, and 2 µM (final concentrations) of each GAIP/RGS4 polypeptide. 50-µl aliquots were removed at the indicated times and added in 750 µl of a 5% (w/v) charcoal slurry in 50 mM NaH2PO4 (pH 2.0). Zero time point was obtained by adding 30 µl of [gamma -32P]GTP-loaded Galpha o1 in charcoal slurry. After vortex, 20 µl of RGS mix was added. Tubes containing charcoal slurry were centrifuged at 4 °C for 15 min at 12,000 × g. 400-µl aliquots were counted by Cerenkov scintillation.

Antibodies-- Antibodies against RGS4 N terminus, RGS4 C terminus, GAIP N terminus, and RGS10 were obtained from Santa Cruz Biotechnology. Full-length GAIP antibodies were raised and characterized as described by De Vries et al. (20). Antibodies against RGS2 and RGS12 were a kind gift of Dr. David P. Siderovski (Amgen Institute, Toronto, Canada).

RT-PCR-- Total RNA was isolated from 11-12-day-old embryonic chick DRG neurons using TRIzol (Life Technologies Inc). Poly(A)+ RNA was prepared using FastTrack (Invitrogen). Primers for RGS4 were a kind gift from Dr. David P. Siderovski. The PCRs were performed with a "touch-down/touch-up" annealing temperature protocol described by Siderovski and colleagues (12). PCR products were gel-purified and subcloned into a TA cloning vector, pCR2.1 (Invitrogen).

Northern Blots-- Chicken RGS4 and GAIP RT-PCR fragments were excised from pCR2.1 by EcoRI digestion and radioactively labeled by random hexanucleotide extension (Roche Molecular Biochemicals) following the manufacturer's suggested procedure. 5 µg of poly(A)+ RNA were loaded per lane and separated by electrophoresis on denaturing formaldehyde 1% agarose gels. Hybridization was done in 50% formamide, 6× SSC, 10× Denhardt's solution, 0.5% SDS, and 100 µg/ml denatured salmon sperm DNA in a hybridization oven (Robbins Scientific, Mountain View, CA) at 42 °C. The blots were washed sequentially with 2× SSC, 0.5% SDS at 25 °C, 1× SSC, 0.25% SDS at 42 °C, and 0.2× SSC, 0.05% SDS at 65 °C, and exposed to film.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

We generated functional recombinant proteins in E. coli tagged on their N termini with a hexahistidine epitope for purification purposes. GAIP-(1-217), RGS4, and GAIP-(79-206) were able to speed up basal GTPase activity of Galpha o1 triggered with 15 mM MgSO4 (Fig. 1B). These results are in agreement with previous reports (14, 15).


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 1.   Inhibition of Ca2+ current by NE. A, time course of desensitization measured as percentage of maximal inhibition produced by 100 µM NE as a function of time. Values representing kinetic slowing are represented by filled circles, and steady-state inhibition is represented by open circles. Values are means ± S.E. (each point represents 5-8 cells). B, effect of GAIP constructs and RGS4 on the rate of GTP hydrolysis by the Galpha o1 protein. 250 nM recombinant Galpha o1 were loaded with [gamma -32P]GTP and stimulated in the presence of MgSO4 and the different RGS proteins. Results are expressed as picomoles of phosphate released after subtraction of the background value (zero time point) and are representative of two experiments.

To test the effects of these RGS proteins, calcium currents were recorded from the cell bodies of embryonic chick sensory neurons 1-3 days after plating. Application of 100 µM NE induced a 55 ± 7% decrease in calcium current. To separate the voltage-dependent (KS) from the voltage-independent (SSI) component, we used a +80-mV, 15-ms pulse with a 5-ms interval between the conditioning and test pulses (5). This inhibition is transient as the response is maximally desensitized by 2 min. The NE-mediated KS and SSI desensitize at different rates (6) (Fig. 1A).

In yeast two-hybrid experiments GAIP interacts more effectively with Galpha i3 and Galpha o than with Galpha i2 (9). This suggested that in chick sensory neurons, GAIP might exhibit differential effects on Go-mediated KS and Gi-mediated SSI. Using tight-seal, whole-cell recording, DRG neuron calcium current was measured before and during prolonged exposure to transmitter. Currents were evoked by a 10-ms voltage step from -80 to 0 mV every 10 s. Cells were equilibrated with control or RGS-containing (0.2-200 nM) internal solution for 10 min prior to transmitter application; calcium current as a function of time was measured to check for any agonist-independent effect that the recombinant protein might have. In control cells (n = 16), NE inhibited N-type calcium current by an average of 40% (25% SSI and 15% KS). In GAIP-treated cells, the KS component was eliminated (n = 14), whereas SSI was unaffected (Fig. 2A). Inclusion of GAIP in the recording solution blocked the Go-mediated pathway. This result was corroborated in experiments in which GABA was used. GABA via GABAB receptors induces kinetic slowing and steady-state inhibition of voltage-dependent calcium channels in chick DRG neurons by pathways mediated through Go (4). GAIP blocked the GABAB-mediated inhibition of the N-type calcium current (Fig. 2A). Inclusion of GAIP in the recording internal solution did not have an effect on the magnitude of the basal calcium current or the percentage of rundown of calcium current over time.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 2.   Effects of GAIP on the magnitude and time course of desensitization of NE-mediated kinetic slowing. A, mean inhibition of calcium current in control cells (open bars) or cells in the presence of 200 nM GAIP (filled bars). Cells were equilibrated for 10 min with control internal recording solution or internal recording solution containing 200 nM GAIP. After equilibration, cells were exposed to 100 µM GABA or NE. B, time course of desensitization of NE-mediated kinetic slowing. Peak calcium current was measured as a function of time, before or during the application of 100 µM NE for control cells (squares, n = 6) and cells equilibrated with 200 (triangles, n = 6) or 2 (circles, n = 7) nM GAIP. C, mean inhibition of calcium current in control cells (open bars) or cells in the presence of a fusion protein containing the RGS domain of GAIP (filled bars). Cells were equilibrated for 10 min with control internal recording solution or internal recording solution containing 200 nM fusion protein. After equilibration, cells were exposed to 100 µM NE. Kinetic slowing and steady-state inhibition were calculated using protocol described under "Experimental Procedures." The number of cells is indicated in parentheses.

Experiments performed using more frequent depolarizations (every 2 s) revealed that the apparent block of the response is a result of an alteration in the time course of the NE-mediated inhibition of calcium. In control cells (Fig. 2B), NE inhibits the calcium current and the effect persists during the experiment for the first 40 s in the presence of agonist. Cells that contained GAIP in the internal recording solution exhibited a maximal recovery in 8 s despite the continued presence of 100 µM NE. This accounts for the lack of response observed when the cells were depolarized every 10 s. Lower concentrations of the protein (2 nM) accelerated the rate of desensitization without altering the magnitude of the response. GAIP failed to alter the time course of the Gi-mediated response or onset of the inhibition.

It has been shown that RGS4 can alter the GTPase activity of both Gi and Gq. Inclusion of 200 nM RGS4 in the internal solution selectively accelerated the time course of desensitization of the NE-SSI without altering the KS component. Lower concentrations of RGS4 were also effective in altering the time course of desensitization (Fig. 3B). Recombinant RGS2, RGS12, and RGS14 (0.1-200 nM) did not have an effect on the magnitude of the response or in the magnitude, extent, or rate of desensitization.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 3.   Effects of RSG4 on the magnitude and time course of desensitization of NE-mediated kinetic slowing. A, mean inhibition of calcium current in control cells (open bars) or cells in the presence of 200 nM RGS4 (filled bars). Cells were equilibrated for 10 min with control internal recording solution or internal recording solution containing 200 nM RGS4. After equilibration, cells were exposed to 100 µM NE. Kinetic slowing and steady-state inhibition were calculated using protocol described under "Experimental Procedures." The number of cells is indicated in parentheses. B, time course of desensitization of NE-mediated kinetic slowing. Peak calcium current was measured as a function of time, before or during the application of 100 µM NE for control cells (squares, n = 4) and cells equilibrated with 200 (triangles, n = 8) or 2 (circles, n = 4) nM RGS4.

A fusion protein containing the RGS core domain of GAIP-(79-206) was used to test whether this domain of the protein was sufficient to alter the time course of desensitization. The fusion protein was introduced into the intracellular environment through passive diffusion from the recording pipette. The core domain of GAIP altered both NE-mediated KS and SSI (Fig. 2C). The rate of desensitization of both inhibitory components was accelerated under these experimental conditions (data not shown). The selectivity of GAIP was lost when the N terminus and C terminus of the protein were removed.

To test whether RGS4 or GAIP plays a role in the desensitization of NE-mediated KS and SSI under physiological conditions, we employed antibodies raised against these proteins to inhibit the endogenous proteins. The antibodies were introduced into sensory neurons through the recording pipette solution and allowed to diffuse into the cytoplasm. Cells were treated with 100 µM NE after 10-12 min. The magnitude of the N-type inhibition, the extent, and the time course of desensitization were compared with cells equilibrated for an equal amount of time with normal internal recording solution.

Antibodies raised against RGS4 N terminus or C terminus (20 ng/µl) slowed the time course of desensitization of NE-mediated SSI (Table I). The KS component was unaffected. Antibodies raised against full-length GAIP or its N terminus (20 ng/µl) increased the half-time for desensitization of NE-mediated KS by a factor of 10. The antibodies did not alter the extent of desensitization. Whereas blocking RGS proteins had a profound effect on the rate of desensitization, no effect was observed on the onset of desensitization, as the initial time at which desensitization could be detected remained unchanged in control and antibody-treated cells. NE-mediated SSI and KS in cells microinjected with antibodies raised against RGS2, RGS12, and RGS10 were no different from control cells (Table I).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Effects of RGS antibodies on the rate of desensitization of NE-mediated steady-state inhibition and kinetic slowing
Values represent mean ± S.E. of five cells.

cDNA fragments encoding RGS domains were generated from poly(A)+ RNA of embryonic chick DRG neurons by RT-PCR using degenerate oligonucleotide primers. Two of the fragments exhibited a high degree of nucleotide and amino acid sequence identity with mammalian GAIP and RGS4, respectively (Fig. 4, A and B). Northern blot analysis of embryonic chick RNA indicated that chick GAIP and RGS4 fragments hybridized at high stringency to transcripts in DRG neuron RNA that are comparable in size to their mammalian counterparts (9, 14). These data suggest that chick DRG neurons express RGS proteins similar to mammalian GAIP and RGS4.


View larger version (48K):
[in this window]
[in a new window]
 
Fig. 4.   Chick RGS genes are expressed in DRG neurons. A and D, alignment of amino acid sequences deduced from chick RT-PCR cDNAs with the proteins that exhibited the highest scores on a BLAST search of the GenBankTM data bases. The sequences are as follows: human RGS4 (accession number U27768), rat RGS8 (AB006013), human RGS3 (1710136), human RGS5 (AB008109), human GAIP (1730186), human GzGAP (AF060877), and bovine retina-specific RGS (U89254). B and E, percentage identity and similarity between chick RGS domains and various mammalian RGS proteins as determined by CLUSTALW pairwise alignment (identity/similarity). C and F, autoradiograms of a Northern blot containing poly(A)+ RNA isolated from chick embryo brain, heart, and DRG neurons. The blot was hybridized with a chick RGS4 probe, stripped, and rehybridized with a radioactively labeled chick GAIP fragment. Numbers on the right of the autoradiograms represent the approximate length in nucleotides of the hybridizing transcripts. ch, chick; h, human; r, rat; GzGAP, regulator of Gz-selective protein signaling; ret, bovine retina specific; St, standards; nt, nucleotides.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Recent reports have shed light on the functional roles of RGS proteins in the nervous system. RGS9 colocalizes with the other signaling components of the phototransduction machinery in the rod outer segment, and in vitro assays have shown that this RGS protein accelerates the rate of GTP hydrolysis of transducin (21). RGS8 coexpressed with a G protein-coupled receptor and a G protein-coupled inwardly rectifying K+ channel accelerated the kinetics of onset and desensitization of the response (22). In hippocampal CA1 neurons, RGS4 blocks the glutamate receptor (GluR5)-mediated inhibition of K+ current by blocking Gq-mediated activation of phospholipase C (23). The question remains whether the RGS proteins can selectively alter transmitter responses mediated by a specific type of G protein.

About nine different RGS domains have been sequenced by RT-PCR in embryonic dorsal root ganglion neurons.3 The questions of why a cell needs multiple RGS proteins and whether there is selectivity in their action arise. Our experiments show that there is selectivity in the effects of RGS proteins and that this could potentially lead to differences in the desensitization of Gi- and Go-mediated pathways. We have shown that the endogenous RGS proteins exhibit selectivity, as blocking RGS4 and GAIP with specific antibodies in sensory neurons altered the rates of desensitization of Gi-mediated SSI and Go-mediated KS, respectively.

The molecular basis for the selectivity of the RGS actions resides in a domain outside of the RGS box, as the RGS domain of GAIP alone did not discriminate between Gi- and Go-mediated pathways. Recent reports have shown that molecular domains outside of the RGS box might be important for the targeting or activity of RGS proteins. The localization of RGS4 to the plasma membrane and GAIP to intracellular membranes seems to be dependent on the N terminus of these molecules (20, 24). Recently, the N-terminal domain of RGS4 (and to a lesser degree, its C-terminal domain) was shown to be important for discrimination between specific receptor signaling complexes (25). The N terminus of RGS12 contains a PDZ domain, which interacts with a chemokine receptor (26), and the C terminus of GAIP interacts with a novel PDZ domain containing protein (27). These interactions might also contribute to their selectivity. Besides its potential role in membrane attachment via its cysteine string motif, the N-terminal domain of GAIP might also play an additional role in the selectivity of this RGS protein.

The RGS box might also contribute to the selectivity. The RGS domains of GAIP and RGS4 are structurally very similar, but the conserved Asn-128 residue in RGS4 that makes closest contact to the Galpha i1 subunit is present as Ser-156 in GAIP (28). Although not yet tested, swapping these residues in both molecules might have effects on their selectivity of interaction with different G protein alpha  subunits.

An interesting observation derived from the experiments is that although RGS proteins play a role in determining the rate of desensitization, blockade by antibodies did not prevent desensitization. A plausible explanation is that another molecule is necessary for the onset of desensitization. We have previously shown that GRK3, a G protein-coupled receptor kinase plays a role in desensitization in embryonic chick sensory neurons (6). Future experiments should address the roles of GRK3 and RGS proteins in the onset and kinetics of desensitization.

    ACKNOWLEDGEMENTS

We acknowledge Dr. Kathleen Dunlap (Tufts University), whose National Institutes of Health Grant NS1642 provided generous support in the initial stages of this project. We thank Dr. Ravi Iyengar for helpful comments on the manuscript.

    FOOTNOTES

* This work was supported by a postdoctoral fellowship from the Massachusetts Medical Foundation, National Institutes of Health Grant NS37443, and The NYC Speaker's Fund for Biomedical Research Award (to M. A. D.-P.), National Research Service Award DA05798 (to J. D. J.), and National Institutes of Health Grant DK17780 (to M. G. F.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Dept. of Pharmacology, Mount Sinai School of Medicine, One Gustave Levy Place, New York, NY 10029. Tel.: 212-824-7532; Fax: 212-831-0114; E-mail: diverm01{at}doc.mssm.edu.

2 M. A. Diversé-Pierluissi, unpublished observation.

3 M. Schiff, J. D. Jordan, and M. A. Diversé-Pierluissi, unpublished observation.

    ABBREVIATIONS

The abbreviations used are: GABA, gamma -aminobutyric acid; DRG, dorsal root ganglion; GAIP, Galpha interacting protein; KS, kinetic slowing; NE, norepinephrine; RGS, regulators of G protein signaling; SSI, steady-state inhibition; RT, reverse transcription; PCR, polymerase chain reaction.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
  1. Hille, B. (1992) Neuron 9, 187-195[Medline] [Order article via Infotrieve]
  2. Beech, D. J., Bernheim, L., and Hille, B. (1992) Neuron 8, 97-106[Medline] [Order article via Infotrieve]
  3. Diversé-Pierluissi, M., and Dunlap, K. (1993) Neuron 10, 753-760[Medline] [Order article via Infotrieve]
  4. Diversé-Pierluissi, M., Goldsmith, P. K., and Dunlap, K. (1994) Neuron 14, 191-200
  5. Luebke, J. I., and Dunlap, K. (1994) Pfluegers. Arch. Eur. J. Physiol. 428, 499-507[Medline] [Order article via Infotrieve]
  6. Diversé-Pierluissi, M., Inglese, J., Stoffel, R. H., Lefkowitz, R. J., and Dunlap, K. (1996) Neuron 16, 579-585[Medline] [Order article via Infotrieve]
  7. Arshavsky, V. Y., and Pugh, E. N. (1998) Neuron 20, 11-14[Medline] [Order article via Infotrieve]
  8. Berman, D. M., and Gilman, A. G. (1998) J. Biol. Chem. 273, 1269-1272[Free Full Text]
  9. De Vries, L., Mousli, M., Wurmser, A., and Farquhar, M. G. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 11916-11920[Abstract]
  10. Dohlman, H. G., and Thorner, J. (1997) J. Biol. Chem. 272, 3871-3874[Free Full Text]
  11. Siderovski, D. P., Hessel, A., Chung, S., Mak, T. W., and Tyers, M. (1996) Curr. Biol. 6, 211-212[Medline] [Order article via Infotrieve]
  12. Snow, B. E., Antonio, L., Suggs, S., Gutstein, H. B., and Siderovski, D. P. (1997) Biochem. Biophys. Res. Commun. 233, 770-777[CrossRef][Medline] [Order article via Infotrieve]
  13. Snow, B. E., Antonio, L., Suggs, S., and Siderovski, D. P. (1998) Gene (Amst.) 206, 247-253[CrossRef][Medline] [Order article via Infotrieve]
  14. Watson, N., Linder, M. E., Druey, K. M., Kehrl, J. H., and Blumer, K. J. (1996) Nature 383, 172-175[CrossRef][Medline] [Order article via Infotrieve]
  15. Berman, D. M., Wilkie, T. M., and Gilman, A. G. (1996) Cell 86, 445-452[Medline] [Order article via Infotrieve]
  16. Hunt, T. W., Fields, T. A., Casey, P. J., and Peralta, E. G. (1996) Nature 383, 175-177[CrossRef][Medline] [Order article via Infotrieve]
  17. Huang, C., Hepler, J. R., Gilman, A. G., and Mumby, S. M. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 6159-6163[Abstract/Free Full Text]
  18. Shuey, D. J., Betty, M., Jones, P. G., Khawaja, X. Z., and Cockett, M. I. (1998) J. Neurochem. 70, 1964-1972[Medline] [Order article via Infotrieve]
  19. Horn, R., and Marty, A. (1988) J. Gen. Physiol. 92, 145-149[Abstract]
  20. De Vries, L., Elenko, E., McCaffery, J. M., Fischer, T., Hubler, L., McQuistan, T., Watson, N., and Farquhar, M. G. (1998) Mol. Biol. Cell 9, 1123-1134[Abstract/Free Full Text]
  21. He, W., Cowan, C. W., and Wensel, T. G. (1998) Neuron 20, 95-102[Medline] [Order article via Infotrieve]
  22. Saitoh, O., Kubo, Y., Miyatani, Y., Asano, T., and Nakata, H. (1997) Nature 390, 525-528[CrossRef][Medline] [Order article via Infotrieve]
  23. Saugstad, J. A., Marino, M. J., Folk, J. A., Hepler, J. R., and Conn, P. J. (1998) J. Neurosci. 18, 905-913[Abstract/Free Full Text]
  24. Srinivasa, S. P., Bernstein, L. S., Blumer, K. J., and Linder, M. E. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 5584-5590[Abstract/Free Full Text]
  25. Zeng, W., Xu, X., Popov, S., Mukhopadhyay, S., Chidiac, P., Swistok, S., Danho, W., Yagaloff, K. A., Fisher, S. L., Ross, E. M., Muallem, S., and Wilkie, T. M. (1998) J. Biol. Chem. 273, 34687-34690[Abstract/Free Full Text]
  26. Snow, B. E., Hall, R. A., Krumins, A. M., Brothers, G. M., Bouchard, D., Brothers, C. A., Chung, S., Mangion, J., Gilman, A. G., Lefkowitz, R. J., and Siderovski, D. P. (1998) J. Biol. Chem. 273, 17749-17755[Abstract/Free Full Text]
  27. De Vries, L., Lou, X., Zhao, G., Zheng, B., and Farquhar, M. G. (1998) Proc. Natl. Acad. Sci. U. S. A. 13, 12340-12345[CrossRef]
  28. Tesmer, J. J., Berman, D. M., Gilman, A. G., and Sprang, S. R. (1998) Cell 89, 251-261


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.